Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...

A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Amyloid pathology typical of Alzheimer's disease (AD) is 50% lower in patients with multiple sclerosis (MS) than in those without the condition, an analysis of plasma biomarker data shows.

Late-onset multiple sclerosis is a form of the disease in which symptoms develop after age 50. Common symptoms include trouble with balance and walking, plus thinking and memory problems.

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients. Annals of Neurology, 2024; 96 (3): 453 DOI: 10.1002/ana.27027 ...

EP: 2. Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression EP: 3. Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis EP: 4.